ロード中...
Autophagy inhibition enhances celecoxib-induced apoptosis in osteosarcoma
Osteosarcoma (OS) is the most prevalent bone malignancy in childhood and adolescence, with highly aggressive and early systemic metastases. Here, we reported that celecoxib, a selective COX-2 inhibitor in the NSAID class, exhibits strong antitumor activity in dose dependent manner in two OS cell lin...
保存先:
| 出版年: | Cell Cycle |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6103699/ https://ncbi.nlm.nih.gov/pubmed/29884091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2018.1467677 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|